Product
Pozelimab + Cemdisiran
Name
VEOPOZ
INN Name
Pozelimab
FDA Approved
Yes
1 clinical trial
1 organization
1 indication
1 document
Indication
Myasthenia GravisClinical trial
Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Symptomatic Generalized Myasthenia GravisStatus: Recruiting, Estimated PCD: 2025-08-29
Document
DailyMed Label: VEOPOZOrganization
Regeneron Pharmaceuticals, Inc.